Searched for: school:SOM
Department/Unit:Otolaryngology
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells
Bayin, N Sumru; Frenster, Joshua D; Sen, Rajeev; Si, Sheng; Modrek, Aram S; Galifianakis, Nataliya; Dolgalev, Igor; Ortenzi, Valerio; Illa-Bochaca, Irineu; Khahera, Anadjeet; Serrano, Jonathan; Chiriboga, Luis; Zagzag, David; Golfinos, John G; Doyle, Werner; Tsirigos, Aristotelis; Heguy, Adriana; Chesler, Mitch; Barcellos-Hoff, Mary Helen; Snuderl, Matija; Placantonakis, Dimitris G
Glioblastoma (GBM) stem cells (GSCs) reside in both hypoxic and vascular microenvironments within tumors. The molecular mechanisms that allow GSCs to occupy such contrasting niches are not understood. We used patient-derived GBM cultures to identify GSC subtypes with differential activation of Notch signaling, which co-exist in tumors but occupy distinct niches and match their metabolism accordingly. Multipotent GSCs with Notch pathway activation reside in perivascular niches, and are unable to entrain anaerobic glycolysis during hypoxia. In contrast, most CD133-expressing GSCs do not depend on canonical Notch signaling, populate tumors regardless of local vascularity and selectively utilize anaerobic glycolysis to expand in hypoxia. Ectopic activation of Notch signaling in CD133-expressing GSCs is sufficient to suppress anaerobic glycolysis and resistance to hypoxia. These findings demonstrate a novel role for Notch signaling in regulating GSC metabolism and suggest intratumoral GSC heterogeneity ensures metabolic adaptations to support tumor growth in diverse tumor microenvironments.
PMCID:5630302
PMID: 29029402
ISSN: 1949-2553
CID: 2738172
Top-down modulation of sensory cortex gates perceptual learning
Caras, Melissa L; Sanes, Dan H
Practice sharpens our perceptual judgments, a process known as perceptual learning. Although several brain regions and neural mechanisms have been proposed to support perceptual learning, formal tests of causality are lacking. Furthermore, the temporal relationship between neural and behavioral plasticity remains uncertain. To address these issues, we recorded the activity of auditory cortical neurons as gerbils trained on a sound detection task. Training led to improvements in cortical and behavioral sensitivity that were closely matched in terms of magnitude and time course. Surprisingly, the degree of neural improvement was behaviorally gated. During task performance, cortical improvements were large and predicted behavioral outcomes. In contrast, during nontask listening sessions, cortical improvements were weak and uncorrelated with perceptual performance. Targeted reduction of auditory cortical activity during training diminished perceptual learning while leaving psychometric performance largely unaffected. Collectively, our findings suggest that training facilitates perceptual learning by strengthening both bottom-up sensory encoding and top-down modulation of auditory cortex.
PMCID:5604044
PMID: 28847938
ISSN: 1091-6490
CID: 2679842
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Lassaletta, Alvaro; Zapotocky, Michal; Mistry, Matthew; Ramaswamy, Vijay; Honnorat, Marion; Krishnatry, Rahul; Guerreiro Stucklin, Ana; Zhukova, Nataliya; Arnoldo, Anthony; Ryall, Scott; Ling, Catriona; McKeown, Tara; Loukides, Jim; Cruz, Ofelia; de Torres, Carmen; Ho, Cheng-Ying; Packer, Roger J; Tatevossian, Ruth; Qaddoumi, Ibrahim; Harreld, Julie H; Dalton, James D; Mulcahy-Levy, Jean; Foreman, Nicholas; Karajannis, Matthias A; Wang, Shiyang; Snuderl, Matija; Nageswara Rao, Amulya; Giannini, Caterina; Kieran, Mark; Ligon, Keith L; Garre, Maria Luisa; Nozza, Paolo; Mascelli, Samantha; Raso, Alessandro; Mueller, Sabine; Nicolaides, Theodore; Silva, Karen; Perbet, Romain; Vasiljevic, Alexandre; Faure Conter, Cecile; Frappaz, Didier; Leary, Sarah; Crane, Courtney; Chan, Aden; Ng, Ho-Keung; Shi, Zhi-Feng; Mao, Ying; Finch, Elizabeth; Eisenstat, David; Wilson, Bev; Carret, Anne Sophie; Hauser, Peter; Sumerauer, David; Krskova, Lenka; Larouche, Valerie; Fleming, Adam; Zelcer, Shayna; Jabado, Nada; Rutka, James T; Dirks, Peter; Taylor, Michael D; Chen, Shiyi; Bartels, Ute; Huang, Annie; Ellison, David W; Bouffet, Eric; Hawkins, Cynthia; Tabori, Uri
Purpose BRAF V600E is a potentially highly targetable mutation detected in a subset of pediatric low-grade gliomas (PLGGs). Its biologic and clinical effect within this diverse group of tumors remains unknown. Patients and Methods A combined clinical and genetic institutional study of patients with PLGGs with long-term follow-up was performed (N = 510). Clinical and treatment data of patients with BRAF V600E mutated PLGG (n = 99) were compared with a large international independent cohort of patients with BRAF V600E mutated-PLGG (n = 180). Results BRAF V600E mutation was detected in 69 of 405 patients (17%) with PLGG across a broad spectrum of histologies and sites, including midline locations, which are not often routinely biopsied in clinical practice. Patients with BRAF V600E PLGG exhibited poor outcomes after chemotherapy and radiation therapies that resulted in a 10-year progression-free survival of 27% (95% CI, 12.1% to 41.9%) and 60.2% (95% CI, 53.3% to 67.1%) for BRAF V600E and wild-type PLGG, respectively ( P < .001). Additional multivariable clinical and molecular stratification revealed that the extent of resection and CDKN2A deletion contributed independently to poor outcome in BRAF V600E PLGG. A similar independent role for CDKN2A and resection on outcome were observed in the independent cohort. Quantitative imaging analysis revealed progressive disease and a lack of response to conventional chemotherapy in most patients with BRAF V600E PLGG. Conclusion BRAF V600E PLGG constitutes a distinct entity with poor prognosis when treated with current adjuvant therapy.
PMCID:5791837
PMID: 28727518
ISSN: 1527-7755
CID: 2640512
Patterns of Change in Facial Skeletal Aging
Paskhover, Boris; Durand, David; Kamen, Emily; Gordon, Neil A
Importance: Research in facial aging has focused on soft-tissue changes rather than bony changes despite evidence of the importance of underlying bony structural changes. Research has also been limited by comparing different patients in separate age groups rather than the same patients over time. Objective: To longitudinally document patterns of change in the facial skeleton and determine a consistent methodology for measuring these changes. Design, Setting, and Participants: Case series study of university hospital system records using facial computed tomographic (CT) images timed at least 8 years apart in adults initially aged 40 to 55 years with no history of facial surgery who required repeated facial imaging that included the entire midface and cranium. Main Outcomes and Measures: Face CTs were analyzed for 3-dimensional constructions and 2-dimensional measurements to document changes in glabellar, piriform, and maxillary angles and piriform height and width. Results: Fourteen patients (5 men, 9 women; mean [SD] age, 51.1 [5.8] years) with mean (SD) follow-up of 9.7 (1.4) years were eligible for 2-dimensional analysis, which revealed statistically significant decreases in mean (SD) glabellar angles (from 68.8 degrees [7.6 degrees ] to 66.5 degrees [8.6 degrees ]) and maxillary angles on both the right (from 82.5 degrees [6.3 degrees ] to 81.0 degrees [7.1 degrees ]) and left (from 83.0 degrees [5.8 degrees ] to 81.0 degrees [7.0 degrees ]), as well as increases in mean (SD) piriform width (from 24.5 [1.6] mm to 25.5 [1.3] mm). Nine patients (3 men, 6 women; mean [SD] age, 51.4 [6.3] years) with mean (SD) follow-up imaging at 9.6 (1.5) years were eligible for 3-dimensional analysis, which revealed statistically significant decreases in mean (SD) maxillary angles (from 56.5 degrees [6.6 degrees ] to 51.6 degrees [7.6 degrees ]) and piriform angles (from 50.8 degrees [3.4 degrees ] to 49.1 degrees [3.4 degrees ]). Statistically significant differences between the sexes were also noted: Initial mean (SD) glabellar angle for men was 61.7 degrees (5.7 degrees ) vs 72.7 degrees (5.4 degrees ) for women, with final values of 57.9 degrees (4.9 degrees ) vs 71.2 degrees (6.0 degrees ). Mean (SD) maxillary angle initial values were 87.8 degrees (6.1 degrees ) (right) and 87.1 degrees (4.9 degrees ) (left) for men, with 79.6 degrees (4.3 degrees ) and 80.6 degrees (5.0 degrees ) for women, respectively. Final values were 87.0 degrees (4.4 degrees ) and 86.9 degrees (4.1 degrees ) for men and 77.7 degrees (6.1 degrees ) and 77.7 degrees (6.2 degrees ) for women, respectively. Mean (SD) piriform height for men was 35.0 (2.0) mm initially and 35.5 (2.1) mm finally, vs 31.3 (2.8) and 31.6 (3.0) mm for women, respectively. Conclusions and Relevance: Our pilot study of repeated CT images of patients over several years supports previous studies of bony facial aging and further characterizes these changes. This study is the first, to our knowledge, to document bony changes of the face in the same group of patients at different time points to better characterize facial aging. We also detail an improved methodology to study bony aging to contribute to additional research in the field. Level of Evidence: NA.
PMCID:5710626
PMID: 28796853
ISSN: 2168-6092
CID: 2664132
Triple-modality treatment in patients with advanced stage tonsil cancer
Roden, Dylan F; Schreiber, David; Givi, Babak
BACKGROUND: Concurrent chemoradiation (CCRT) and upfront surgery followed by adjuvant therapy both are recommended treatment options for patients with advanced stage squamous cell carcinoma (SCC) of the tonsil. To the authors' knowledge, the question of whether surgical-based treatments can achieve better survival compared with CCRT has never been compared in a clinical trial. The authors analyzed the National Cancer Data Base to measure the impact of different treatment modalities on overall survival (OS). METHODS: All patients aged =70 years diagnosed with clinical stage III to IVB (excluding T4B) SCC of the tonsil from 1998 through 2011 were selected. Analysis was limited to patients receiving CCRT, surgery plus CCRT, or surgery followed by adjuvant radiotherapy (RT). OS was compared using the Kaplan-Meier method and log-rank test. Univariable and multivariable hazards analyses were performed to identify factors significant for survival. Propensity score matching was performed. RESULTS: There were 16,891 patients who met the inclusion criteria. The most common treatment was CCRT (8123 patients; 48.1%), followed by surgery plus CCRT (5249; 31.1%) and surgery plus RT (3519 patients; 20.8%). Patients treated with surgery plus CCRT were found to have the highest 3-year OS rate (88.5%) followed by those treated with surgery plus RT (84%) and CCRT (74.2%) (P<.0001). In a propensity score-matched subpopulation of 4962 patients, the 3-year OS rate was 90.2% for those treated with surgery plus CCRT, 84.9% for those treated with surgery plus RT, and 82.1% for those treated with definitive CCRT (P<.0001). CONCLUSIONS: Patients with advanced stage SCC of the tonsil who underwent surgery followed by CCRT had the greatest OS. Patients undergoing upfront surgery may avoid chemotherapy without jeopardizing survival. Triple-modality therapy may provide a survival benefit for a subset of patients with advanced stage tonsil cancer. Cancer 2017;123:3269-76. (c) 2017 American Cancer Society.
PMID: 28440876
ISSN: 1097-0142
CID: 2758522
AN UNEXPECTED ORAL FINDING: A CASE OF GRANULOCYTIC SARCOMA
Shah, S; Brar, B; Phelan, J; Kerr, R
CINAHL:124721914
ISSN: 2212-4403
CID: 2735792
Quality measurement for rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society
Rudmik, Luke; Mattos, Jose; Schneider, John; Manes, Peter R; Stokken, Janalee K; Lee, Jivianne; Higgins, Thomas S; Schlosser, Rodney J; Reh, Douglas D; Setzen, Michael; Soler, Zachary M
BACKGROUND:Measuring quality outcomes is an important prerequisite to improve quality of care. Rhinosinusitis represents a high value target to improve quality of care because it has a high prevalence of disease, large economic burden, and large practice variation. In this study we review the current state of quality measurement for management of both acute (ARS) and chronic rhinosinusitis (CRS). METHODS:The major national quality metric repositories and clearinghouses were queried. Additional searches included the American Academy of Otolaryngology-Head and Neck Surgery database, PubMed, and Google to attempt to capture any additional quality metrics. RESULTS:Seven quality metrics for ARS and 4 quality metrics for CRS were identified. ARS metrics focused on appropriateness of diagnosis (n = 1), antibiotic prescribing (n = 4), and radiologic imaging (n = 2). CRS quality metrics focused on appropriateness of diagnosis (n = 1), radiologic imaging (n = 1), and measurement of patient quality of life (n = 2). The Physician Quality Reporting System (PQRS) currently tracks 3 ARS quality metrics and 1 CRS quality metric. There are no outcome-based rhinosinusitis quality metrics and no metrics that assess domains of safety, patient-centeredness, and timeliness of care. CONCLUSIONS:The current status of quality measurement for rhinosinusitis has focused primarily on the quality domain of efficiency and process measures for ARS. More work is needed to develop, validate, and track outcome-based quality metrics along with CRS-specific metrics. Although there has been excellent work done to improve quality measurement for rhinosinusitis, there remain major gaps and challenges that need to be considered during the development of future metrics.
PMID: 28665549
ISSN: 2042-6984
CID: 3074332
Adult acute supraglottitis: Analysis of 358 patients for predictors of airway intervention
Shapira Galitz, Yael; Shoffel-Havakuk, Hagit; Cohen, Oded; Halperin, Doron; Lahav, Yonatan
OBJECTIVES/HYPOTHESIS:Acute supraglottitis is a potentially life-threatening condition due to rapid onset upper airway obstruction. The study aimed to characterize adult acute supraglottitis patients and to recognize factors associated with an aggressive disease course. STUDY DESIGN:Retrospective chart review. METHODS:All adult acute supraglottitis patients admitted to a single academic medical center between 2000 and 2014 were included and their medical charts reviewed. The main outcome measures were airway intervention and mortality. RESULTS:Three hundred fifty-eight patients were enrolled. Mean age was 53 years (range, 16-92 years), with 62.8% males. Sore throat (79%) and dysphagia (70.9%) were the most common symptoms. Stridor (3.6%), tachypnea (5.7%), and dyspnea (6.4%) were uncommon but significantly associated with airway intervention. The epiglottis was most commonly involved (67%). Involvement of the epiglottis and aryepiglottic folds showed a trend of correlation to airway intervention. Blood glucose levels, C-reactive protein (CRP) levels, and relative neutrophilia were significantly higher in patients admitted to the intensive care unit or requiring airway intervention. Thirty-four patients (9.5%) required intensive care unit admission. Sixteen patients (4.4%) required airway intervention. Recurrent episodes of supraglottitis, seen in 19 patients, were more common in males (P = .048), and tended to have a more severe clinical course, requiring more airway interventions (P = .005) and intensive care unit admissions (P = .016). CONCLUSIONS:The typical high risk patient-a male, with dyspnea and stridor, presenting with edema of the epiglottis and aryepiglottic folds, elevated CRP, hyperglycemia, and a history of recurrent episodes-should warrant more aggressive treatment and closer observation. LEVEL OF EVIDENCE:4 Laryngoscope, 127:2106-2112, 2017.
PMID: 28493349
ISSN: 1531-4995
CID: 4039342
OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients
Viet, Chi T; Dang, Dongmin; Aouizerat, Bradley E; Miaskowski, Christine; Ye, Yi; Viet, Dan T; Ono, Kentaro; Schmidt, Brian L
Cancer patients in pain require high doses of opioids and quickly become opioid-tolerant. Previous studies have shown that both chronic cancer pain and high dose opioid use lead to mu-opioid receptor down-regulation. In this study we explore down-regulation of OPRM1, the mu-opioid receptor gene, as a mechanism f,or opioid tolerance in the setting of opioid use for cancer pain. We demonstrate in a cohort of 84 cancer patients that high dose opioid use correlates with OPRM1 hypermethylation in peripheral leukocytes of these patients. We then reverse-translate our clinical findings by creating a mouse cancer pain model; we create opioid tolerance in the mouse cancer model to mimic opioid tolerance in the cancer patients. Using this model we determine the functional significance of OPRM1 methylation on cancer pain and opioid tolerance. We focus on two main cells within the cancer microenvironment: the cancer cell and the neuron. We show that targeted re-expression of mu-opioid receptor on cancer cells inhibits mechanical and thermal hypersensitivity, and prevents opioid tolerance, in the mouse model. The resultant analgesia and protection against opioid tolerance are likely due to preservation of mu-opioid receptor expression on the cancer-associated neurons.
PMCID:5918413
PMID: 28456745
ISSN: 1528-8447
CID: 2547002
Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma
Lee, Anna; Givi, Babak; Osborn, Virginia W; Schwartz, David; Schreiber, David
OBJECTIVES/HYPOTHESIS: National Cancer Care Network guidelines suggest consideration of adjuvant radiation even for early stage adenoid cystic carcinoma of the salivary glands. We used the National Cancer Data Base (NCDB) to analyze practice patterns and outcomes of postoperative radiotherapy for adenoid cystic carcinomas. STUDY DESIGN: Retrospective NCDB review. METHODS: Patients with nonmetastatic adenoid cystic carcinoma of the parotid, submandibular, or another major salivary gland from 2004 to 2012 were identified. Information was collected regarding receipt of postoperative radiation. The Kaplan-Meier method was used to assess overall survival and Cox regression analysis to assess impact of covariates. RESULTS: There were 1,784 patients included. Median age was 57 years old and median follow up was 47.5 months. Of the patients, 72.4% of underwent partial/total parotidectomy and 73.6% received postoperative radiation. The 5-year survival was 72.5% for those receiving surgery alone compared to 82.4% for those receiving postoperative radiation (P < .001). On subgroup analysis, this survival difference favoring postoperative radiation was significant for pT1-2N0 (P < .001), pT3-4N0 (P = .047), pTanyN+ (P < .001), and for positive margins (P = .001), but not for negative margins (P = .053). On multivariable analysis, postoperative radiation remained associated with improved overall survival (hazard ratio [HR] = 0.63, 95% confidence interval: 0.50-0.80, P < .001). The utilization of intensity modulated radiation therapy (IMRT) increased from 16.9% in 2004 to 56.3% in 2012 (P < .001). There was no survival benefit for IMRT over three-dimensional radiation therapy (HR = 0.84, P = .19). CONCLUSIONS: Postoperative radiation therapy for salivary adenoid cystic carcinoma was associated with improved survival even for those with early-stage disease. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:2057-2062, 2017.
PMID: 28194862
ISSN: 1531-4995
CID: 2758512